Dr. Christian Meyer discusses potential changes to the EU pharmaceutical regulation and their possible impact on data and market protection timelines for medicinal products.
All publications
EU pharmaceutical reforms propose changes to regulatory protection periods, Managing IP 2024
To the publication
